Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1995-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.80.8.7543114PMID 7543114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults

  1994cited by this paper
• Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters

  1993cited by this paper
• Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children.

  1993cited by this paper
• Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

  1993cited by this paper
• Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol.

  1993cited by this paper
• Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.

  1992cited by this paper
• Human growth hormone replacement therapy: pharmacological and clinical aspects.

  1991cited by this paper
• Diurnal pattern of plasma growth hormone-binding protein in man.

  1990cited by this paper
• Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.

  1990cited by this paper
• A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.

  1990cited by this paper
• Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration.

  1990cited by this paper
• Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

  1989cited by this paper
• METABOLIC AND HORMONAL RESPONSES TO EXOGENOUS HYPERTHERMIA IN MAN

  1989cited by this paper
• Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1.

  1989cited by this paper
• Electrical impedance in assessing human body composition: the BIA method.

  1988cited by this paper
• Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.

  1988cited by this paper
• Acute down-regulation of the somatogenic receptors in rat liver by a single injection of growth hormone.

  1988cited by this paper
• Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats.

  1988cited by this paper
• Blood Glucose, Lactate, Pyruvate, Glycerol, 3-Hydroxybutyrate and Acetoacetate Measurements in Man Using a Centrifugal Analyser with a Fluorimetric Attachment

  1988cited by this paper
• The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone.

  1987cited by this paper
• Effect of free fatty acids on blood amino acid levels in human.

  1986cited by this paper
• Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection.

  1986cited by this paper
• Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats.

  1985cited by this paper
• Characterization of growth hormone release in response to external heating. Comparison to exercise induced release.

  1984cited by this paper
• The Effect of Small but Sustained Elevations in Circulating Growth Hormone on Fuel Metabolism in Growth Hormone Deficiency

  1984cited by this paper
• Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children.

  1983cited by this paper
• Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.

  1983cited by this paper
• Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats.

  1982cited by this paper
• Dose regimens of human growth hormone: effects of continuous infusion and of a gelatin vehicle on growth in rats and rate of absorption in rabbits.

  1980cited by this paper
• Skin temperature and subcutaneous adipose blood flow in man.

  1980cited by this paper
• Use of growth hormone-gel.

  1979cited by this paper
• Age-related change in the twenty-four-hour spontaneous secretion of growth hormone.

  1972cited by this paper
• A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay.

  1969cited by this paper
• Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

  1968cited by this paper

• Study of long-acting vs daily growth hormone: peak levels, AUC, action duration, and IGF-1

  2024cites this paper
• Hyaluronic acid in drug delivery applications

  2019cites this paper
• Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons

  2019cites this paper
• Challenges and future for the delivery of growth hormone therapy.

  2018cites this paper
• Inflammatory Diseases and Growth: Effects on the GH–IGF Axis and on Growth Plate

  2017cites this paper
• Biochemical investigations in diagnosis and follow up of acromegaly

  2017cites this paper
• Comparison of pulsatile vs. continuous administration of human placental growth hormone in female C57BL/6J mice

  2016cites this paper
• Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

  2016cites this paper
• Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein.

  2015cites this paper
• Control of rhGH Release Profile from PEG-PAF Thermogel.

  2015cites this paper
• Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients.

  2014cites this paper
• A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

  2014cites this paper
• Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.

  2014cites this paper
• Pluronic-based core/shell nanoparticles for drug delivery and diagnosis.

  2013cites this paper
• Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement

  2013cites this paper
• Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients.

  2013influential citation
• Multi-core vesicle nanoparticles for controlled delivery of protein drug

  2012cites this paper
• GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses.

  2012cites this paper
• Biological rhythms, drug delivery, and chronotherapeutics

  2012cites this paper
• A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life

  2012cites this paper
• Circadian aspects of growth hormone-insulin-like growth factor axis function in patients with lung cancer.

  2012cites this paper
• Injectable hydrogel for sustained protein release by salt-induced association of hyaluronic acid nanogel.

  2012cites this paper
• Intra-Articular Injections for the Treatment of Osteoarthritis: Focus on the Clinical Use of Several Regimens

  2012cites this paper
• Neuroendocrine modulation of GH-IGF1 axis function

  2011cites this paper
• Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics.

  2011cites this paper
• The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(organophosphazene)-polyethylenimine conjugate hydrogels.

  2011cites this paper
• Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.

  2011cites this paper
• The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.

  2011cites this paper
• Long-Acting Growth Hormone Analogues

  2011cites this paper
• Age-related changes of GH-IGF1 axis function

  2011cites this paper
• Hormone Deficiency: A Single-dose, Dose-escalation Trial Investigating

  2011cites this paper
• Neuroendocrine axes function in healthy aging: Evaluation of predictive and manipulable blood serum indexes

  2011cites this paper
• WITHDRAWN: Neuroendocrine axes function in healthy aging: Evaluation of predictive and manipulable blood serum indexes.

  2010cites this paper
• Additive Effects of Intra-articular Injection of Growth Hormone and Hyaluronic Acid in Rabbit Model of Collagenase-induced Osteoarthritis

  2010cites this paper
• Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.

  2010cites this paper
• Chronobiologic study of the GH-IGF1 axis and the ageing immune system

  2010cites this paper
• Cationic and thermosensitive protamine conjugated gels for enhancing sustained human growth hormone delivery.

  2010cites this paper
• 776, 780 ̧ ̧ Ãâ·Â¿ä

  2010cites this paper
• Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.

  2010cites this paper
• Development of a sustained-release recombinant human growth hormone formulation.

  2009cites this paper
• The pattern of growth hormone delivery to peripheral tissues determines insulin-like growth factor-1 and lipolytic responses in obese subjects.

  2009cites this paper
• IGF-I measurements in the monitoring of GH therapy

  2007cites this paper
• A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist

  2007cites this paper
• Prospects for the Development of Long-Acting Formulations of Human Somatropin

  2006cites this paper
• Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency.

  2005cites this paper
• Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.

  2005cites this paper
• A new sustained‐release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile

  2005cites this paper
• Clinical pharmacological aspects of growth hormone administration.

  2004cites this paper
• Characterization and In Vivo Study of Sustained-Release Formulation of Human Growth Hormone Using Sodium Hyaluronate

  2004cites this paper
• A new animal model for evaluation of long‐term growth rate over one month by rhGH/PLGA microcapsule formulations

  2003cites this paper
• Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections.

  2003cites this paper
• Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique.

  2003cites this paper
• Neuroendocrine alterations in lung cancer patients.

  2003cites this paper
• Growth hormone replacement therapy for adults: into the new millennium.

  2002cites this paper
• Growth hormone disturbances in adolescents with type 1 (insulin-dependent) diabetes mellitus : differentiating the GH signal

  2002cites this paper
• Optimizing gh therapy in adults and children.

  2001cites this paper
• Effect of long‐term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency

  2001cites this paper
• Role of dosage regimen in controlling indirect pharmacodynamic responses.

  2001cites this paper
• Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.

  2001cites this paper
• Growth Hormone Secretion In Congestive Heart Failure

  2001cites this paper
• Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism

  2000cites this paper
• Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.

  2000cites this paper
• Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients.

  2000cites this paper
• Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue.

  1999cites this paper
• Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue

  1999cites this paper
• Decreased serum levels of insulin-like growth factor (IGF)-I in patients with lung cancer: temporal relationship with growth hormone (GH) levels.

  1999cites this paper
• Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

  1998cites this paper
• Role of dosage regimen in controlling indirect pharmacodynamic responses.

  1998cites this paper
• The Effect of Different Growth Hormone Administration Frequencies on Growth in Growth Hormone-Deficient Patients

  1998cites this paper
• Cytokines in endocrine function.

  1998cites this paper
• Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

  1998cites this paper
• Different Effects of Continuous and Intermittent Patterns of Growth Hormone Administration on Lipoprotein Levels inGrowth Hormone-Deficient Patients

  1998cites this paper
• The effect of different growth hormone administration frequencies on growth in growth hormone-deficient patients.

  1998cites this paper
• The Growth Hormone Secretory Pattern and Statural Growth

  1998cites this paper
• Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect

  1997cites this paper
• Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone.

  1997cites this paper
• Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions

  1997cites this paper
• The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres

  1997cites this paper
• Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters.

  1997cites this paper
• Diurnal variation in serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH‐deficient adults

  1997cites this paper
• In vivo characterization of sustained-release formulations of human growth hormone.

  1997cites this paper
• Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development.

  1997cites this paper
• Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat.

  1996cites this paper
• A month–long effect from a single injection of microencapsulated human growth hormone

  1996cites this paper
• Phenotypic correction of dwarfism by constitutive expression of growth hormone.

  1996cites this paper
• Chronobiology in the endocrine system.

  1989cites this paper